BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37712389)

  • 1. A novel KMT2A::DCP1B rearrangement in chronic neutrophilic leukemia.
    Yang L; Yang X; Zhuang Y; Wang J; Chen X; Hu W; Shan D; Rong R; Zhou X; Xiao S
    Int J Lab Hematol; 2024 Feb; 46(1):165-168. PubMed ID: 37712389
    [No Abstract]   [Full Text] [Related]  

  • 2. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The KMT2A rearrangement is an early event prior to KMT2A-PTD in AML patients with both molecular aberrations.
    Huang J; Zhu Y; Li J; Yang G; Zhang S
    Ann Hematol; 2023 Feb; 102(2):495-497. PubMed ID: 36525029
    [No Abstract]   [Full Text] [Related]  

  • 4. A new breakpoint fusion gene involving KMT2A::EDC4 rearrangement in de novo acute myeloid leukemia.
    Hu DY; Wang M; Shen K; Pan JL; Guo YS; Zhang ZB; Zhang FH; Yin J; Chen SN
    Int J Lab Hematol; 2023 Aug; 45(4):596-598. PubMed ID: 36811287
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital acute myeloid leukaemia with KMT2A rearrangement.
    Wan Ariffin E; Jones H; Bhatnagar N
    Br J Haematol; 2018 Jul; 182(2):169. PubMed ID: 29797490
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
    Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia.
    Zhou X; Zhang P; Aryal S; Zhang L; Lu R
    Leukemia; 2023 Jan; 37(1):226-230. PubMed ID: 36309561
    [No Abstract]   [Full Text] [Related]  

  • 8. Myeloid lineage switch in
    Bataller A; Abuasab T; McCall D; Wang W; Cuglievan B; Issa GC; Jabbour E; Short N; DiNardo CD; Tang G; Garcia-Manero G; Kantarjian HM; Sasaki K
    Haematologica; 2024 Jan; 109(1):293-297. PubMed ID: 37646654
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloid sarcoma concurrent with de novo KMT2A gene-rearranged infantile acute lymphoblastic leukemia.
    Abe H; Hamada S; Sakiyama H; Oshiro T; Kato M; Yagi T; Matsuda T; Higa T; Hyakuna N; Nakanishi K
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29573. PubMed ID: 35044058
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
    Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
    Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
    Pediatr Blood Cancer; 2022 Mar; 69(3):e29428. PubMed ID: 34766724
    [No Abstract]   [Full Text] [Related]  

  • 12. FLT3
    Hyrenius-Wittsten A; Pilheden M; Falqués-Costa A; Eriksson M; Sturesson H; Schneider P; Wander P; Garcia-Ruiz C; Liu J; Ågerstam H; Hultquist A; Lilljebjörn H; Stam RW; Järås M; Hagström-Andersson AK
    Leukemia; 2019 Sep; 33(9):2310-2314. PubMed ID: 30953031
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloid Sarcoma of the Testis in Children: Clinicopathologic and Immunohistochemical Characteristics With KMT2A (MLL) Gene Rearrangement Correlation.
    El Jamal SM; Salama A; Marcellino BK; Abulsayen HA; Zhou X; Hassan M; Firpo-Betancourt A; Saad AG
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):501-507. PubMed ID: 31241561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed-phenotype acute leukemia with t(4;11)(q21;q23)
    Liu H
    Blood; 2019 Mar; 133(11):1265. PubMed ID: 30872272
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new rearrangement giving rise to a very rare MLL-MLLT10 fusion mRNA in an infant acute myeloid leukemia.
    Burillo-Sanz S; Morales-Camacho R; Vargas MT; Carrillo E; Pérez-Soto I; García-Lozano JR
    Cancer Genet; 2015 Mar; 208(3):101-2. PubMed ID: 25475940
    [No Abstract]   [Full Text] [Related]  

  • 18. The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia.
    Matsuo H; Goyama S; Kamikubo Y; Adachi S
    Haematologica; 2015 Mar; 100(3):e116-7. PubMed ID: 25740107
    [No Abstract]   [Full Text] [Related]  

  • 19. GAS6 Oncogene and Reverse MLLT3-KMT2A Duplications in an Infant with Acute Myeloid Leukemia and a Novel Complex Hyperdiploid Karyotype: Detailed High-Resolution Molecular Cytogenetic Studies.
    Capela de Matos RR; Ney Garcia DR; Cifoni E; Othman MAK; Tavares de Souza M; Carboni EK; Ferreira GM; Liehr T; Ribeiro RC; M Silva ML
    Cytogenet Genome Res; 2017; 152(1):33-37. PubMed ID: 28595195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
    Tong J; Zhang L; Liu H; Xu X; Zheng C; Yao W; Zhu X; Tang B; Wan X; Song K; Zhang X; Sun G; Sun Z
    Ann Hematol; 2021 May; 100(5):1303-1309. PubMed ID: 33469688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.